Having established TP5’s T cell-dependent antitumor mechanisms, we investigated its impact on T cell functional states, particularly its capacity to counteract T cell exhaustion—a fundamental barrier to effective cancer immunotherapy [4]. This evidence concerns the gene TMPO and cancer.